{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:21:20Z","timestamp":1792138880012,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory demyelinating disease of the central nervous system (CNS) accompanied by blood-brain barrier (BBB) disruption. Dysfunction in microglial lipid metabolism is believed to be closely associated with the neuropathology of NMOSD. However, there is limited evidence on the functional relevance of circulating lipids in CNS demyelination, cellular metabolism, and microglial function. Here, we found that serum low-density lipoprotein (LDL) was positively correlated with markers of neurological damage in NMOSD patients. In addition, we demonstrated in a mouse model of NMOSD that LDL penetrates the CNS through the leaky BBB, directly activating microglia. This activation leads to excessive phagocytosis of myelin debris, inhibition of lipid metabolism, and increased glycolysis, ultimately exacerbating myelin damage. We also found that therapeutic interventions aimed at reducing circulating LDL effectively reversed the lipid metabolic dysfunction in microglia and mitigated the demyelinating injury in NMOSD. These findings shed light on the molecular and cellular mechanisms underlying the positive correlation between serum LDL and neurological damage, highlighting the potential therapeutic target for lowering circulating lipids to alleviate the acute demyelinating injury in NMOSD.<\/jats:p>","DOI":"10.1007\/s12264-023-01166-y","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T06:02:59Z","timestamp":1705384979000},"page":"1104-1114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Serum LDL Promotes Microglial Activation and Exacerbates Demyelinating Injury in Neuromyelitis Optica Spectrum Disorder"],"prefix":"10.1007","volume":"40","author":[{"given":"Man","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hui","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Xiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Fan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Wei","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo-Qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai-Shi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5162-3150","authenticated-orcid":false,"given":"Chuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"1166_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","volume":"6","author":"S Jarius","year":"2020","unstructured":"Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B. Neuromyelitis optica. Nat Rev Dis Primers 2020, 6: 85.","journal-title":"Nat Rev Dis Primers"},{"key":"1166_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","volume":"96","author":"V Papp","year":"2021","unstructured":"Papp V, Magyari M, Aktas O, Berger T, Broadley SA, Cabre P. Worldwide incidence and prevalence of neuromyelitis optica: A systematic review. Neurology 2021, 96: 59\u201377.","journal-title":"Neurology"},{"key":"1166_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.msard.2018.12.002","volume":"27","author":"Y Wu","year":"2019","unstructured":"Wu Y, Zhong L, Geng J. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models. Mult Scler Relat Disord 2019, 27: 412\u2013418.","journal-title":"Mult Scler Relat Disord"},{"key":"1166_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"MC Papadopoulos","year":"2012","unstructured":"Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012, 11: 535\u2013544.","journal-title":"Lancet Neurol"},{"key":"1166_CR5","first-page":"4025","volume":"130","author":"T Chen","year":"2020","unstructured":"Chen T, Lennon VA, Liu YU, Bosco DB, Li Y, Yi MH, et al. Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion. J Clin Invest 2020, 130: 4025\u20134038.","journal-title":"J Clin Invest"},{"key":"1166_CR6","first-page":"3961","volume":"130","author":"Z Moinfar","year":"2020","unstructured":"Moinfar Z, Zamvil SS. Microglia complement astrocytes in neuromyelitis optica. J Clin Invest 2020, 130: 3961\u20133964.","journal-title":"J Clin Invest"},{"key":"1166_CR7","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","volume":"69","author":"SR Hinson","year":"2007","unstructured":"Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007, 69: 2221\u20132231.","journal-title":"Neurology"},{"key":"1166_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00401-017-1734-6","volume":"134","author":"L Tradtrantip","year":"2017","unstructured":"Tradtrantip L, Yao X, Su T, Smith AJ, Verkman AS. Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica. Acta Neuropathol 2017, 134: 35\u201344.","journal-title":"Acta Neuropathol"},{"key":"1166_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fncel.2019.00142","volume":"13","author":"APB da Silva","year":"2019","unstructured":"da Silva APB, Souza DG, Souza DO, Machado DC, Sato DK. Role of glutamatergic excitotoxicity in neuromyelitis optica spectrum disorders. Front Cell Neurosci 2019, 13: 142.","journal-title":"Front Cell Neurosci"},{"key":"1166_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/jnnp-2011-300434","volume":"83","author":"F Shimizu","year":"2012","unstructured":"Shimizu F, Sano Y, Takahashi T, Haruki H, Saito K, Koga M, et al. Sera from neuromyelitis optica patients disrupt the blood-brain barrier. J Neurol Neurosurg Psychiatry 2012, 83: 288\u2013297.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1166_CR11","doi-asserted-by":"publisher","first-page":"e1076","DOI":"10.1212\/NXI.0000000000001076","volume":"8","author":"Y Takeshita","year":"2021","unstructured":"Takeshita Y, Fujikawa S, Serizawa K, Fujisawa M, Matsuo K, Nemoto J, et al. New BBB model reveals that IL-6 blockade suppressed the BBB disorder, preventing onset of NMOSD. Neurol Neuroimmunol Neuroinflamm 2021, 8: e1076.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1166_CR12","doi-asserted-by":"publisher","first-page":"639757","DOI":"10.3389\/fendo.2021.639757","volume":"12","author":"I Pineda-Torra","year":"2021","unstructured":"Pineda-Torra I, Siddique S, Waddington KE, Farrell R, Jury EC. Disrupted lipid metabolism in multiple sclerosis: A role for liver X receptors? Front Endocrinol (Lausanne) 2021, 12: 639757.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1166_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2174\/1567205012666150921103426","volume":"13","author":"AM Giudetti","year":"2016","unstructured":"Giudetti AM, Romano A, Lavecchia AM, Gaetani S. The role of brain cholesterol and its oxidized products in alzheimer\u2019s disease. Curr Alzheimer Res 2016, 13: 198\u2013205.","journal-title":"Curr Alzheimer Res"},{"key":"1166_CR14","doi-asserted-by":"publisher","first-page":"101981","DOI":"10.1016\/j.msard.2020.101981","volume":"40","author":"EB Cho","year":"2020","unstructured":"Cho EB, Cho HJ, Choi M, Seok JM, Shin HY, Kim BJ, et al. Low high-density lipoprotein cholesterol and high triglycerides lipid profile in neuromyelitis optica spectrum disorder: Associations with disease activity and disability. Mult Scler Relat Disord 2020, 40: 101981.","journal-title":"Mult Scler Relat Disord"},{"key":"1166_CR15","doi-asserted-by":"publisher","first-page":"616301","DOI":"10.3389\/fimmu.2021.616301","volume":"12","author":"T Chen","year":"2021","unstructured":"Chen T, Bosco DB, Ying Y, Tian DS, Wu LJ. The emerging role of microglia in neuromyelitis optica. Front Immunol 2021, 12: 616301.","journal-title":"Front Immunol"},{"key":"1166_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","volume":"15","author":"AF Lloyd","year":"2019","unstructured":"Lloyd AF, Miron VE. The pro-remyelination properties of microglia in the central nervous system. Nat Rev Neurol 2019, 15: 447\u2013458.","journal-title":"Nat Rev Neurol"},{"key":"1166_CR17","doi-asserted-by":"publisher","first-page":"105290","DOI":"10.1016\/j.nbd.2021.105290","volume":"152","author":"S Yang","year":"2021","unstructured":"Yang S, Qin C, Hu ZW, Zhou LQ, Yu HH, Chen M, et al. Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system. Neurobiol Dis 2021, 152: 105290.","journal-title":"Neurobiol Dis"},{"key":"1166_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/jnc.14053","volume":"142","author":"LE Yu","year":"2017","unstructured":"Yu LE, Lai CL, Lee CT, Wang JY. Highly electronegative low-density lipoprotein L5 evokes microglial activation and creates a neuroinflammatory stress via Toll-like receptor 4 signaling. J Neurochem 2017, 142: 231\u2013245.","journal-title":"J Neurochem"},{"key":"1166_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015, 85: 177\u2013189.","journal-title":"Neurology"},{"key":"1166_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12974-021-02266-0","volume":"18","author":"X Ma","year":"2021","unstructured":"Ma X, Qin C, Chen M, Yu HH, Chu YH, Chen TJ, et al. Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder. J Neuroinflammation 2021, 18: 201.","journal-title":"J Neuroinflammation"},{"key":"1166_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbi.2017.04.023","volume":"65","author":"Z Wang","year":"2017","unstructured":"Wang Z, Guo W, Liu Y, Gong Y, Ding X, Shi K, et al. Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes. Brain Behav Immun 2017, 65: 173\u2013182.","journal-title":"Brain Behav Immun"},{"key":"1166_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-017-0934-2","volume":"14","author":"X Xu","year":"2017","unstructured":"Xu X, Gao W, Cheng S, Yin D, Li F, Wu Y, et al. Anti-inflammatory and immunomodulatory mechanisms of atorvastatin in a murine model of traumatic brain injury. J Neuroinflammation 2017, 14: 167.","journal-title":"J Neuroinflammation"},{"key":"1166_CR23","first-page":"2376","volume":"2011","author":"TN Luong","year":"2011","unstructured":"Luong TN, Carlisle HJ, Southwell A, Patterson PH. Assessment of motor balance and coordination in mice using the balance beam. J Vis Exp 2011, 2011: 2376.","journal-title":"J Vis Exp"},{"key":"1166_CR24","doi-asserted-by":"publisher","first-page":"14290","DOI":"10.1073\/pnas.1819343116","volume":"116","author":"M Baydyuk","year":"2019","unstructured":"Baydyuk M, Cha DS, Hu J, Yamazaki R, Miller EM, Smith VN, et al. Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye. Proc Natl Acad Sci U S A 2019, 116: 14290\u201314299.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1166_CR25","doi-asserted-by":"publisher","DOI":"10.3791\/63511","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yang S, Chen M, Tian DS, Qin C. Isolation of mouse primary microglia by magnetic-activated cell sorting in animal models of demyelination. J Vis Exp 2022, https:\/\/doi.org\/10.3791\/63511.","journal-title":"J Vis Exp"},{"key":"1166_CR26","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.immuni.2021.04.022","volume":"54","author":"L Shi","year":"2021","unstructured":"Shi L, Sun Z, Su W, Xu F, Xie D, Zhang Q, et al. Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke. Immunity 2021, 54: 1527\u20131542.","journal-title":"Immunity"},{"key":"1166_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fncel.2016.00203","volume":"10","author":"J Yang","year":"2016","unstructured":"Yang J, Cheng X, Shen J, Xie B, Zhao X, Zhang Z, et al. A novel approach for amplification and purification of mouse oligodendrocyte progenitor cells. Front Cell Neurosci 2016, 10: 203.","journal-title":"Front Cell Neurosci"},{"key":"1166_CR28","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, et al. TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron 2020, 105: 837\u2013854.","journal-title":"Neuron"},{"key":"1166_CR29","doi-asserted-by":"publisher","first-page":"108835","DOI":"10.1016\/j.celrep.2021.108835","volume":"34","author":"K Shen","year":"2021","unstructured":"Shen K, Reichelt M, Kyauk RV, Ngu H, Shen YA, Foreman O, et al. Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination. Cell Rep 2021, 34: 108835.","journal-title":"Cell Rep"},{"key":"1166_CR30","doi-asserted-by":"publisher","first-page":"e485","DOI":"10.1016\/j.jtcvs.2019.12.075","volume":"161","author":"M Kajimoto","year":"2021","unstructured":"Kajimoto M, Nuri M, Sleasman JR, Charette KA, Nelson BR, Portman MA. Inhaled nitric oxide reduces injury and microglia activation in porcine hippocampus after deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg 2021, 161: e485\u2013e498.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1166_CR31","first-page":"321","volume":"2023","author":"C Qin","year":"2023","unstructured":"Qin C, Chen M, Dong MH, Yang S, Zhang H, You YF, et al. Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders. Brain 2023, 2023: 321.","journal-title":"Brain"},{"key":"1166_CR32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1161\/CIRCULATIONAHA.121.056491","volume":"145","author":"JK Wang","year":"2022","unstructured":"Wang JK, Li Y, Zhao XL, Liu YB, Tan J, Xing YY, et al. Ablation of plasma prekallikrein decreases low-density lipoprotein cholesterol by stabilizing low-density lipoprotein receptor and protects against atherosclerosis. Circulation 2022, 145: 675\u2013687.","journal-title":"Circulation"},{"key":"1166_CR33","doi-asserted-by":"publisher","first-page":"e010838","DOI":"10.1161\/JAHA.118.010838","volume":"8","author":"N Apaijai","year":"2019","unstructured":"Apaijai N, Moisescu DM, Palee S, McSweeney CM, Saiyasit N, Maneechote C, et al. Pretreatment with PCSK9 inhibitor protects the brain against cardiac ischemia\/reperfusion injury through a reduction of neuronal inflammation and amyloid beta aggregation. J Am Heart Assoc 2019, 8: e010838.","journal-title":"J Am Heart Assoc"},{"key":"1166_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","volume":"143","author":"Z Qi","year":"2021","unstructured":"Qi Z, Hu L, Zhang J, Yang W, Liu X, Jia D, et al. PCSK9 (Proprotein Convertase Subtilisin\/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36. Circulation 2021, 143: 45\u201361.","journal-title":"Circulation"},{"key":"1166_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12264-020-00583-7","volume":"37","author":"F Dong","year":"2021","unstructured":"Dong F, Liu D, Jiang F, Liu Y, Wu X, Qu X, et al. Conditional deletion of Foxg1 alleviates demyelination and facilitates remyelination via the Wnt signaling pathway in cuprizone-induced demyelinated mice. Neurosci Bull 2021, 37: 15\u201330.","journal-title":"Neurosci Bull"},{"key":"1166_CR36","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.7150\/ijms.61153","volume":"18","author":"W Li","year":"2021","unstructured":"Li W, Liu J, Tan W, Zhou Y. The role and mechanisms of Microglia in Neuromyelitis Optica Spectrum Disorders. Int J Med Sci 2021, 18: 3059\u20133065.","journal-title":"Int J Med Sci"},{"key":"1166_CR37","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3988\/jcn.2020.16.4.562","volume":"16","author":"J Jang","year":"2020","unstructured":"Jang J, Nam Y, Choi Y, Shin NY, An JY, Ahn KJ, et al. Paramagnetic rims in multiple sclerosis and neuromyelitis optica spectrum disorder: A quantitative susceptibility mapping study with 3-T MRI. J Clin Neurol 2020, 16: 562\u2013572.","journal-title":"J Clin Neurol"},{"key":"1166_CR38","doi-asserted-by":"publisher","first-page":"103280","DOI":"10.1016\/j.msard.2021.103280","volume":"56","author":"M Niiranen","year":"2021","unstructured":"Niiranen M, Kontkanen A, J\u00e4\u00e4skel\u00e4inen O, Tertsunen HM, Selander T, Hartikainen P, et al. Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis. Mult Scler Relat Disord 2021, 56: 103280.","journal-title":"Mult Scler Relat Disord"},{"key":"1166_CR39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","volume":"25","author":"O Preische","year":"2019","unstructured":"Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease. Nat Med 2019, 25: 277\u2013283.","journal-title":"Nat Med"},{"key":"1166_CR40","doi-asserted-by":"publisher","first-page":"e2209990120","DOI":"10.1073\/pnas.2209990120","volume":"120","author":"LQ Zhou","year":"2023","unstructured":"Zhou LQ, Dong MH, Hu ZW, Tang Y, Chu YH, Chen M, et al. Staged suppression of microglial autophagy facilitates regeneration in CNS demyelination by enhancing the production of linoleic acid. Proc Natl Acad Sci U S A 2023, 120: e2209990120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1166_CR41","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/s41467-021-21428-5","volume":"12","author":"A Colombo","year":"2021","unstructured":"Colombo A, Dinkel L, M\u00fcller SA, Sebastian Monasor L, Schifferer M, Cantuti-Castelvetri L, et al. Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microglia. Nat Commun 2021, 12: 1158.","journal-title":"Nat Commun"},{"key":"1166_CR42","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci 2020, 23: 194\u2013208.","journal-title":"Nat Neurosci"},{"key":"1166_CR43","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.cmet.2020.09.013","volume":"32","author":"MN Artyomov","year":"2020","unstructured":"Artyomov MN, Van den Bossche J. Immunometabolism in the single-cell era. Cell Metab 2020, 32: 710\u2013725.","journal-title":"Cell Metab"},{"key":"1166_CR44","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/jamaneurol.2015.4807","volume":"73","author":"L Negrotto","year":"2016","unstructured":"Negrotto L, Farez MF, Correale J. Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis. JAMA Neurol 2016, 73: 520\u2013528.","journal-title":"JAMA Neurol"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-023-01166-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-023-01166-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-023-01166-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T07:39:24Z","timestamp":1723016364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-023-01166-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1166"],"URL":"https:\/\/doi.org\/10.1007\/s12264-023-01166-y","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"12 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}